(Q24247945)

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Changes in Pulmonary Function Test Results After 1 Year of Therapy as Predictors of Survival in Patients With Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Recent advances in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Classification and natural history of the idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Colchicine Versus Prednisone as Treatment of Usual Interstitial Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

7 January 2021

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

7 January 2021

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

7 January 2021

Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

7 January 2021

Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002880

7 January 2021

10.1002/14651858.CD002880

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12917934

1 reference

Consolidated OpenCitations Corpus – April 2017